- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Immunotherapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oncology accounting for % of the Immunotherapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, and Celgene, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunotherapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Market segment by Application can be divided into
Oncology
Inflammation
Central Nervous System
Others
The key market players for global Immunotherapy market are listed below:
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunotherapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immunotherapy, with price, sales, revenue and global market share of Immunotherapy from 2019 to 2022.
Chapter 3, the Immunotherapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunotherapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Immunotherapy market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunotherapy.
Chapter 13, 14, and 15, to describe Immunotherapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Immunotherapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immunotherapy Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Non-Specific Immunotherapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Immunotherapy Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Inflammation
1.3.4 Central Nervous System
1.3.5 Others
1.4 Global Immunotherapy Market Size & Forecast
1.4.1 Global Immunotherapy Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Immunotherapy Sales in Volume (2017-2028)
1.4.3 Global Immunotherapy Price (2017-2028)
1.5 Global Immunotherapy Production Capacity Analysis
1.5.1 Global Immunotherapy Total Production Capacity (2017-2028)
1.5.2 Global Immunotherapy Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunotherapy Market Drivers
1.6.2 Immunotherapy Market Restraints
1.6.3 Immunotherapy Trends Analysis
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Immunotherapy Product and Services
2.1.4 Abbvie Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen, Inc.
2.2.1 Amgen, Inc. Details
2.2.2 Amgen, Inc. Major Business
2.2.3 Amgen, Inc. Immunotherapy Product and Services
2.2.4 Amgen, Inc. Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Immunotherapy Product and Services
2.3.4 Biogen Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Immunotherapy Product and Services
2.4.4 Bristol-Myers Squibb Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Immunotherapy Product and Services
2.5.4 Celgene Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Immunotherapy Product and Services
2.6.4 Johnson & Johnson Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Immunotherapy Product and Services
2.7.4 Merck Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Immunotherapy Product and Services
2.8.4 Novartis Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Immunotherapy Product and Services
2.9.4 Pfizer Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Immunotherapy Product and Services
2.10.4 Roche Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Immunotherapy Breakdown Data by Manufacturer
3.1 Global Immunotherapy Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Immunotherapy Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Immunotherapy
3.4 Market Concentration Rate
3.4.1 Top 3 Immunotherapy Manufacturer Market Share in 2021
3.4.2 Top 6 Immunotherapy Manufacturer Market Share in 2021
3.5 Global Immunotherapy Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Immunotherapy Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immunotherapy Market Size by Region
4.1.1 Global Immunotherapy Sales in Volume by Region (2017-2028)
4.1.2 Global Immunotherapy Revenue by Region (2017-2028)
4.2 North America Immunotherapy Revenue (2017-2028)
4.3 Europe Immunotherapy Revenue (2017-2028)
4.4 Asia-Pacific Immunotherapy Revenue (2017-2028)
4.5 South America Immunotherapy Revenue (2017-2028)
4.6 Middle East and Africa Immunotherapy Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Immunotherapy Sales in Volume by Type (2017-2028)
5.2 Global Immunotherapy Revenue by Type (2017-2028)
5.3 Global Immunotherapy Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Immunotherapy Sales in Volume by Application (2017-2028)
6.2 Global Immunotherapy Revenue by Application (2017-2028)
6.3 Global Immunotherapy Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Immunotherapy Sales by Type (2017-2028)
7.2 North America Immunotherapy Sales by Application (2017-2028)
7.3 North America Immunotherapy Market Size by Country
7.3.1 North America Immunotherapy Sales in Volume by Country (2017-2028)
7.3.2 North America Immunotherapy Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Immunotherapy Sales by Type (2017-2028)
8.2 Europe Immunotherapy Sales by Application (2017-2028)
8.3 Europe Immunotherapy Market Size by Country
8.3.1 Europe Immunotherapy Sales in Volume by Country (2017-2028)
8.3.2 Europe Immunotherapy Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Immunotherapy Sales by Type (2017-2028)
9.2 Asia-Pacific Immunotherapy Sales by Application (2017-2028)
9.3 Asia-Pacific Immunotherapy Market Size by Region
9.3.1 Asia-Pacific Immunotherapy Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Immunotherapy Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Immunotherapy Sales by Type (2017-2028)
10.2 South America Immunotherapy Sales by Application (2017-2028)
10.3 South America Immunotherapy Market Size by Country
10.3.1 South America Immunotherapy Sales in Volume by Country (2017-2028)
10.3.2 South America Immunotherapy Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immunotherapy Sales by Type (2017-2028)
11.2 Middle East & Africa Immunotherapy Sales by Application (2017-2028)
11.3 Middle East & Africa Immunotherapy Market Size by Country
11.3.1 Middle East & Africa Immunotherapy Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Immunotherapy Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Immunotherapy and Key Manufacturers
12.2 Manufacturing Costs Percentage of Immunotherapy
12.3 Immunotherapy Production Process
12.4 Immunotherapy Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Immunotherapy Typical Distributors
13.3 Immunotherapy Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Immunotherapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Immunotherapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbvie Basic Information, Manufacturing Base and Competitors
Table 4. Abbvie Major Business
Table 5. Abbvie Immunotherapy Product and Services
Table 6. Abbvie Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Amgen, Inc. Major Business
Table 9. Amgen, Inc. Immunotherapy Product and Services
Table 10. Amgen, Inc. Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Biogen Basic Information, Manufacturing Base and Competitors
Table 12. Biogen Major Business
Table 13. Biogen Immunotherapy Product and Services
Table 14. Biogen Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Immunotherapy Product and Services
Table 18. Bristol-Myers Squibb Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Celgene Basic Information, Manufacturing Base and Competitors
Table 20. Celgene Major Business
Table 21. Celgene Immunotherapy Product and Services
Table 22. Celgene Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Immunotherapy Product and Services
Table 26. Johnson & Johnson Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Immunotherapy Product and Services
Table 30. Merck Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Immunotherapy Product and Services
Table 34. Novartis Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Immunotherapy Product and Services
Table 38. Pfizer Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Roche Basic Information, Manufacturing Base and Competitors
Table 40. Roche Major Business
Table 41. Roche Immunotherapy Product and Services
Table 42. Roche Immunotherapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Immunotherapy Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Immunotherapy Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Immunotherapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Immunotherapy Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Immunotherapy Production Site of Key Manufacturer
Table 48. Immunotherapy New Entrant and Capacity Expansion Plans
Table 49. Immunotherapy Mergers & Acquisitions in the Past Five Years
Table 50. Global Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 51. Global Immunotherapy Sales by Region (2023-2028) & (K Units)
Table 52. Global Immunotherapy Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Immunotherapy Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 55. Global Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 56. Global Immunotherapy Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Immunotherapy Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Immunotherapy Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Immunotherapy Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 61. Global Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 62. Global Immunotherapy Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Immunotherapy Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Immunotherapy Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Immunotherapy Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 67. North America Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 68. North America Immunotherapy Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Immunotherapy Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 71. North America Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 72. North America Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 73. North America Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 74. Europe Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 75. Europe Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 76. Europe Immunotherapy Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Immunotherapy Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 79. Europe Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 80. Europe Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 81. Europe Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Immunotherapy Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Immunotherapy Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Immunotherapy Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 90. South America Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 91. South America Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 92. South America Immunotherapy Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Immunotherapy Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 95. South America Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 96. South America Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 97. South America Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Immunotherapy Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Immunotherapy Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Immunotherapy Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 106. Immunotherapy Raw Material
Table 107. Key Manufacturers of Immunotherapy Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Immunotherapy Typical Distributors
Table 111. Immunotherapy Typical Customers
List of Figures
Figure 1. Immunotherapy Picture
Figure 2. Global Immunotherapy Revenue Market Share by Type in 2021
Figure 3. Monoclonal Antibodies
Figure 4. Therapeutic Vaccines
Figure 5. Checkpoint Inhibitors
Figure 6. Non-Specific Immunotherapy
Figure 7. Global Immunotherapy Revenue Market Share by Application in 2021
Figure 8. Oncology
Figure 9. Inflammation
Figure 10. Central Nervous System
Figure 11. Others
Figure 12. Global Immunotherapy Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Immunotherapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Immunotherapy Sales (2017-2028) & (K Units)
Figure 15. Global Immunotherapy Price (2017-2028) & (US$/Unit)
Figure 16. Global Immunotherapy Production Capacity (2017-2028) & (K Units)
Figure 17. Global Immunotherapy Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Immunotherapy Market Drivers
Figure 19. Immunotherapy Market Restraints
Figure 20. Immunotherapy Market Trends
Figure 21. Global Immunotherapy Sales Market Share by Manufacturer in 2021
Figure 22. Global Immunotherapy Revenue Market Share by Manufacturer in 2021
Figure 23. Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Immunotherapy Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Immunotherapy Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Immunotherapy Sales Market Share by Region (2017-2028)
Figure 27. Global Immunotherapy Revenue Market Share by Region (2017-2028)
Figure 28. North America Immunotherapy Revenue (2017-2028) & (USD Million)
Figure 29. Europe Immunotherapy Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Immunotherapy Revenue (2017-2028) & (USD Million)
Figure 31. South America Immunotherapy Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Immunotherapy Revenue (2017-2028) & (USD Million)
Figure 33. Global Immunotherapy Sales Market Share by Type (2017-2028)
Figure 34. Global Immunotherapy Revenue Market Share by Type (2017-2028)
Figure 35. Global Immunotherapy Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Immunotherapy Sales Market Share by Application (2017-2028)
Figure 37. Global Immunotherapy Revenue Market Share by Application (2017-2028)
Figure 38. Global Immunotherapy Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Immunotherapy Sales Market Share by Type (2017-2028)
Figure 40. North America Immunotherapy Sales Market Share by Application (2017-2028)
Figure 41. North America Immunotherapy Sales Market Share by Country (2017-2028)
Figure 42. North America Immunotherapy Revenue Market Share by Country (2017-2028)
Figure 43. United States Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Immunotherapy Sales Market Share by Type (2017-2028)
Figure 47. Europe Immunotherapy Sales Market Share by Application (2017-2028)
Figure 48. Europe Immunotherapy Sales Market Share by Country (2017-2028)
Figure 49. Europe Immunotherapy Revenue Market Share by Country (2017-2028)
Figure 50. Germany Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Immunotherapy Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Immunotherapy Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Immunotherapy Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Immunotherapy Revenue Market Share by Region (2017-2028)
Figure 59. China Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Immunotherapy Sales Market Share by Type (2017-2028)
Figure 66. South America Immunotherapy Sales Market Share by Application (2017-2028)
Figure 67. South America Immunotherapy Sales Market Share by Country (2017-2028)
Figure 68. South America Immunotherapy Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Immunotherapy Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Immunotherapy Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Immunotherapy Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Immunotherapy Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Immunotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Immunotherapy in 2021
Figure 80. Manufacturing Process Analysis of Immunotherapy
Figure 81. Immunotherapy Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
